Ignite Creation Date:
2025-12-24 @ 4:48 PM
Ignite Modification Date:
2026-02-03 @ 9:14 AM
Study NCT ID:
NCT03491150
Status:
TERMINATED
Last Update Posted:
2020-07-13
First Post:
2018-03-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
Sponsor:
Hoffmann-La Roche
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BN40031
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None